66993-084 NDC - SUMATRIPTAN (SUMATRIPTAN)

Drug Information

Product NDC: 66993-084

Proprietary Name: SUMATRIPTAN

Non Proprietary Name: sumatriptan

Active Ingredient(s):
  • 6 mg/.5mL SUMATRIPTAN SUCCINATE


Administration Route(s): SUBCUTANEOUS

Dosage Form(s): INJECTION, SOLUTION

Pharmacy Class(es):
  • Serotonin 1b Receptor Agonists [MoA];
  • Serotonin 1d Receptor Agonists [MoA];
  • Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Labeler Information

Labeler Name: Prasco Laboratories
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020080
Marketing Category: NDA AUTHORIZED GENERIC
Start Marketing Date:7/1/2020

Package Information

No. Package Code Package Description Billing Unit
166993-084-792 SYRINGE in 1 CARTON (66993-084-79) / .5 mL in 1 SYRINGEML
266993-084-981 PACKAGE in 1 CARTON (66993-084-98) / 2 SYRINGE in 1 PACKAGE / .5 mL in 1 SYRINGEML

NDC Record

Field Name Field Value Definition
PRODUCT NDC66993-084The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMESUMATRIPTANThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEsumatriptanThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEINJECTION, SOLUTIONThe translation of the dosage form Code submitted by the firm.
ROUTE NAMESUBCUTANEOUSThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE7/1/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMENDA AUTHORIZED GENERICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERNDA020080This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEPrasco LaboratoriesName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMESUMATRIPTAN SUCCINATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6 
ACTIVE INGRED UNITmg/.5mL 
PHARM CLASSESSerotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023